Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Leach

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Toxicologic Pathology|December 24, 1998
Vacuolation in renal tubular epithelium of Cd-1 mice: an incidental findingR C Johnson, B J Dovey-Hartman, J Syed, et al.
Toxicologic Pathology|February 27, 2015
Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part 2. Antisense OligonucleotidesJeffery A Engelhardt, Pierluigi Fant, Silvia Guionaud, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 14, 2017
Bayesian Networks to Compare Pest Control Interventions on Commodities Along Agricultural Production ChainsJ Holt, A W Leach, S Johnson, et al.
The Journal of Experimental Medicine|February 9, 2000
Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcomaT Y Yang, S C Chen, M W Leach, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 9, 2014
Comparative nonclinical assessments of the proposed biosimilar PF-05280014 and trastuzumab (Herceptin(®))Susan Hurst, Anne M Ryan, Chee-Keng Ng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature deathM T Wiekowski, M W Leach, E W Evans, et al.
Toxicologic Pathology|January 30, 2025
Scientific and Regulatory Policy Committee Points to Consider: Proposal and Recommendations to Reduce Euthanasia of Control Nonhuman Primates in Nonclinical Toxicity StudiesMagali Guffroy, Tara Arndt, Erio Barale-Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 StudyTaofeek K Owonikoko, Suzanne E Dahlberg, Gabriel L Sica, et al.
Toxicologic Pathology|October 8, 2010
Use of tissue cross-reactivity studies in the development of antibody-based biopharmaceuticals: history, experience, methodology, and future directionsMichael W Leach, Wendy G Halpern, Carol W Johnson, et al.
Regulatory Toxicology and Pharmacology : RTP|January 24, 2021
Classic and evolving approaches to evaluating cross reactivity of mAb and mAb-like molecules - A survey of industry 2008-2019Timothy K MacLachlan, Shari Price, Joy Cavagnaro, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Toxicologic Pathology|December 24, 1998
Vacuolation in renal tubular epithelium of Cd-1 mice: an incidental findingR C Johnson, B J Dovey-Hartman, J Syed, et al.
Toxicologic Pathology|February 27, 2015
Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part 2. Antisense OligonucleotidesJeffery A Engelhardt, Pierluigi Fant, Silvia Guionaud, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 14, 2017
Bayesian Networks to Compare Pest Control Interventions on Commodities Along Agricultural Production ChainsJ Holt, A W Leach, S Johnson, et al.
The Journal of Experimental Medicine|February 9, 2000
Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcomaT Y Yang, S C Chen, M W Leach, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 9, 2014
Comparative nonclinical assessments of the proposed biosimilar PF-05280014 and trastuzumab (Herceptin(®))Susan Hurst, Anne M Ryan, Chee-Keng Ng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature deathM T Wiekowski, M W Leach, E W Evans, et al.
Toxicologic Pathology|January 30, 2025
Scientific and Regulatory Policy Committee Points to Consider: Proposal and Recommendations to Reduce Euthanasia of Control Nonhuman Primates in Nonclinical Toxicity StudiesMagali Guffroy, Tara Arndt, Erio Barale-Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 StudyTaofeek K Owonikoko, Suzanne E Dahlberg, Gabriel L Sica, et al.
Toxicologic Pathology|October 8, 2010
Use of tissue cross-reactivity studies in the development of antibody-based biopharmaceuticals: history, experience, methodology, and future directionsMichael W Leach, Wendy G Halpern, Carol W Johnson, et al.
Regulatory Toxicology and Pharmacology : RTP|January 24, 2021
Classic and evolving approaches to evaluating cross reactivity of mAb and mAb-like molecules - A survey of industry 2008-2019Timothy K MacLachlan, Shari Price, Joy Cavagnaro, et al.
Pageof 13